Larson Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Larson Financial Group's JAZZ Position: Q3 2026 in Review
Larson Financial Group increased its Jazz Pharmaceuticals (JAZZ) stake by 198% in Q3 2026, buying an estimated $346K and bringing the position to 2,110 shares worth $489K. The position accounts for 0.01% of the portfolio, ranked #597.
Larson Financial Group first reported a position in JAZZ in Q4 2018 and has held it in 25 quarters since. 668 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Larson Financial Group held 2,110 shares of Jazz Pharmaceuticals worth $489K as of Q3 2026.
- Larson Financial Group bought 1,401 Jazz Pharmaceuticals shares in Q3 2026, an estimated $346K.
- Jazz Pharmaceuticals made up 0.01% of Larson Financial Group's portfolio in Q3 2026, its #597 holding.
- Larson Financial Group first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 25 quarters since.
- 668 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.